These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5803305)

  • 1. Inhibition of dopamine beta-hydroxylase by aromatic and alkyl thioureas.
    Johnson GA; Boukma SJ; Kim EG
    J Pharmacol Exp Ther; 1969 Aug; 168(2):229-34. PubMed ID: 5803305
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-hydroxyindole levels in rat brain after inhibition of dopamine -hydroxylase.
    Johnson GA; Kim EG; Boukma SJ
    J Pharmacol Exp Ther; 1972 Mar; 180(3):539-46. PubMed ID: 5012781
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of dopamine-beta-hydroxylase by disulfiram in vivo.
    Musacchio JM; Goldstein M; Anagnoste B; Poch G; Kopin IJ
    J Pharmacol Exp Ther; 1966 Apr; 152(1):56-61. PubMed ID: 5937402
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo inhibition of dopamine beta-hydroxylase by 1-phenyl-3-(2-thiazolyl)-2-thiourea (U-14,624).
    Johnson GA; Boukma SJ; Kim EG
    J Pharmacol Exp Ther; 1970 Jan; 171(1):80-7. PubMed ID: 5410940
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative aspects of the replacement of norepinephrine by dopamine as a sympathetic transmitter after inhibition of dopamine-beta-hydroxylase by disulfiram.
    Thoenen H; Haefely W; Gey KF; Huerlimann A
    J Pharmacol Exp Ther; 1967 May; 156(2):246-51. PubMed ID: 6026255
    [No Abstract]   [Full Text] [Related]  

  • 6. Regional distribution and metabolism of H3-tyramine in the rat brain.
    Goldstein M; Anagnoste B; Yamamoto A; Felch WC
    J Pharmacol Exp Ther; 1970 Feb; 171(2):196-204. PubMed ID: 4391786
    [No Abstract]   [Full Text] [Related]  

  • 7. Tyrosine hydroxylase inhibitors.
    Moore KE; Dominic JA
    Fed Proc; 1971; 30(3):859-70. PubMed ID: 4324974
    [No Abstract]   [Full Text] [Related]  

  • 8. Tryptophan hydroxylase inhibitors.
    Koe BK
    Fed Proc; 1971; 30(3):886-96. PubMed ID: 4252531
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenylethyldithiocarbamate: a new dopamine-beta-hydroxylase inhibitor.
    Jonsson J; Grobecker H; Gunne LM
    J Pharm Pharmacol; 1967 Mar; 19(3):201-3. PubMed ID: 4382347
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of dopamine beta-hydroxylase by fusaric acid (5-butylpicolinic acid) in vitro and in vivo.
    Nagatsu T; Hidaka H; Kuzuya H; Takeya K; Umezawa H
    Biochem Pharmacol; 1970 Jan; 19(1):35-44. PubMed ID: 5507649
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biochemical mechanism of toxicity of fungicides of the dithiocarbamate series: inhibitory action on dopamine -hydroxylase activity].
    Truhaut R; Guérinot F; Bohuon C
    Ann Pharm Fr; 1971 Feb; 29(2):117-23. PubMed ID: 5559013
    [No Abstract]   [Full Text] [Related]  

  • 12. 2-mercaptobenzothiazole, an inhibitor of dopamine beta-hydroxylase.
    Johnson GA; Boukma SJ; Platz PA
    J Pharm Pharmacol; 1970 Sep; 22(9):710-2. PubMed ID: 4394766
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic oral treatment with disulfiram on dopamine-beta-hydroxylase and biogenic amines.
    Lippmann W
    Eur J Pharmacol; 1968 Apr; 3(1):84-6. PubMed ID: 5654674
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of amphetamine derivatives on brain dopamine and noradrenaline.
    Breese GR; Kopin IJ; Weise VK
    Br J Pharmacol; 1970 May; 38(3):537-45. PubMed ID: 4909707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of disulfiram and ascorbic acid on catecholamine content in rat brain.
    Izquierdo JA; Jofré IJ; Acevedo C
    J Pharm Pharmacol; 1972 Apr; 24(4):330-2. PubMed ID: 4402844
    [No Abstract]   [Full Text] [Related]  

  • 16. L-DOPA induced effects on motor activity in mice after inhibition of dopamine-beta-hydroxylase.
    Strömberg U; Svensson TH
    Psychopharmacologia; 1971; 19(1):53-60. PubMed ID: 5089105
    [No Abstract]   [Full Text] [Related]  

  • 17. Blockade of L-dopa reversal of reserpine-induced conditioned avoidance response suppression by disulfiram.
    Seiden LS; Peterson DD
    J Pharmacol Exp Ther; 1968 Sep; 163(1):84-90. PubMed ID: 5673718
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of dopamine-beta-hydroxylase inhibition on the cardiovascular and respiratory actions of dopamine in rats.
    Riancho JA; del Arco C; Pazos A; Flórez J
    Rev Esp Fisiol; 1982 Dec; 38(4):461-9. PubMed ID: 7170431
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine- -hydroxylase inhibition by dimethyldithiocarbamate and related compounds.
    Lippmann W; Lloyd K
    Biochem Pharmacol; 1969 Oct; 18(10):2507-16. PubMed ID: 5403987
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of dopamine -hydroxylase by 5-phenoxymethyl-2-oxazolidinethiones.
    Johnson GA; Kim EG; Boukma SJ; Lednicer D; Youngdale GA
    J Med Chem; 1972 Mar; 15(3):327-9. PubMed ID: 5059221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.